Topics

Articles

An estimated 64,070 deaths recorded; meanwhile, private equity flows into addiction centers

Pharma needs better internal policies to manage its increasing patient interaction

In the midst of the opioid crisis, drug distributors need to address DEA oversight

Observers are critical of the $465-million penalty as too lenient

New location, following Brexit, will be decided in November

Meanwhile, opioid manufacturers and distributors contend with multiple DEA penalties

Site lists manufacturers’ policies and criteria for experimental access

95% of consumers don’t know about online pharmacy certification

August, December and February meetings target unresolved technical issues

GAO report notes FDA’s 99% acceptance rate for ‘expanded access’, but legislators press on